Arthur Ventures
ActiveFiled to raiseMinneapolis, MNHealthcare, BiotechnologyLast fund filed July 2025
2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Arthur Ventures VI Affiliates | July 2025 | $11M | $11M | 35 |
| Arthur Ventures Buyouts I | March 2025 | $200M | $200M | 69 |
| Arthur Ventures VI | March 2025 | $395M | $395M | 80 |
| Arthur Ventures Growth V | March 2025 | $205M | $205M | 91 |
| Arthur Ventures Growth IV | February 2023 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
4 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Ryan Kruizenga | Active | Enterprise software, Cybersecurity, Data & analytics | 15 |
Classified sectors of Arthur Ventures’s own portfolio companies, based on 31 with a verified or cited source.
| Firm | Shared boards | Companies |
|---|---|---|
| Baird Venture Partners | 1 | Catalyze |
| BVP | 1 | Catalyze |
| Elephant Partners | 1 | ThreatLocker |
| Transformation Capital | 1 |
| $170M |
| $170M |
| 100 |
| Arthur Ventures VFiled to raise in 2023, with no closing reported yet. | 2023 | $300M | $0 | 0 |
| Arthur Ventures Growth IV Affiliates FundFiled to raise in 2023, with no closing reported yet. | 2023 | $1.9M | $0 | 0 |
| Arthur Ventures V Affiliates FundFiled to raise in 2023, with no closing reported yet. | 2023 | $2.1M | $0 | 0 |
| Arthur Ventures Growth III Affiliates Fund | September 2021 | $1.8M | $1.8M | 16 |
| Arthur Ventures IV Affiliates Fund | September 2021 | $2.1M | $2.1M | 18 |
| Arthur Ventures Growth IIIFiled to raise in 2021, with no closing reported yet. | 2021 | $150M | $0 | 0 |
| Arthur Ventures IVFiled to raise in 2021, with no closing reported yet. | 2021 | $225M | $0 | 0 |
| Arthur Ventures 2020 | November 2019 | $125M | $109M | 42 |
| Arthur Ventures 2017 Opportunity Fund | February 2019 | $30M | $30M | 39 |
| Arthur Ventures 2013 Opportunity Fund | June 2017 | $18M | $18M | 52 |
| Arthur Ventures 2017 | 2017 | $50M | $48M | 86 |
| 4 |
| Patrick Meenan | Selective | Enterprise software, Developer tools & infrastructure, Digital health | 12 | 2 |
| Andrew HeimNot on the current fund | Quiet | None listed | 0 | 0 |
| James BurgumNot on the current fund | Quiet | Food & agriculture, Climate & energy, Digital health | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Arthur Ventures’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Protenus |
| Vida Longevity | 1 | Circadian Risk |
A shared board seat: a company where filings name a Arthur Ventures partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.